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Age-related macular degeneration (AMD) is the leading 
cause of vision loss among older adults in industrialized 
nations [1]. One of the first signs of AMD is the 
presence of drusen and extracellular basal deposits in 
Bruch’s membrane (BM) [2], leading to BM thickening, 
and ultimately is associated with injury to the retinal 
pigmented epithelium (RPE), choroid and 
photoreceptors [3-5]. With age, esterified cholesterol 
associated in lipoprotein-like particles accumulate sub-
retinally in BM deposits [6-10].  
 
Lipids in the RPE mostly originate from spent 
photoreceptor outer segments, and are exocytosed 
through the base of the RPE to be eliminated via the 
choroid [11-13]. However, RPE cells also take-up 
oxidized lipids from their cell base [14, 15], suggesting 
they may be involved in clearing the sub-retinal space 
from such deposits [16]. Accumulation of lipoprotein- 
and lipid-containing sub-RPE and BM debris implies an 
imbalance in the accumulation/clearance of these 
products, leading to cytotoxicity [17, 18]. Correspon-
dingly, high fat cholesterol diet (HFHC)-fed mice 
deficient in low-density lipoprotein (LDL) receptor 
ligand ApoE (ApoE-/-) and rabbits on fat-enriched diet, 
feature high LDL and oxidized LDL (oxLDL) plasma 
levels [19-21] and exhibit ultrastructural retinal changes 
similar to those observed in human AMD [22], 
including BM thickening and BM lipid deposits [23-
25]. These findings support the concept that improper 
clearance of dietary lipids may influence the 
development of AMD [26]. 
 
The RPE and microvascular endothelium contain a 
number of scavenger receptors involved in uptake and 
metabolism of oxidized lipids [27, 28]. Of the various 
scavenger receptors CD36 is a principal receptor of 
oxidized phospholipid [15] expressed at the basolateral 
side of RPE as well as on microvascular endothelial 
cells and macrophages [29-33]. Interestingly, a 
polymorphism of CD36 gene (in the non-coding region 
[possibly associated with its increased expression]) is 
protective against AMD [34]. We previously 
demonstrated that mice with CD36 gene disruption 
revealed a progressive age-dependent photoreceptor 
death and choroidal involution [32]. We hereby 
hypothesized that CD36 participates in oxLDL uptake 
in RPE and correspondingly in (clearance of) sub-
retinal deposits. Our findings reveal that uptake of 
oxLDL in RPE is CD36-dependent and that a deficiency 
in CD36 leads to accumulation of sub-retinal deposits 
and oxLDL, despite fed a regular diet; conversely, 
stimulation of CD36 reduces sub-retinal deposits and 











































oxLDL uptake by RPE cells is CD36-dependent 
 
Blood levels of oxLDL increase with age [40] and upon 
ingestion of high cholesterol diet [20], as corroborated 
(Figure 1A). Since CD36 clears circulating oxLDL [29], 
we tested if CD36 deficiency would lead to 
accumulation of oxLDL in the sub-retinal region. 
CD36-deficient mice presented abundant sub-retinal 
oxLDL accumulation (Figure 1B,C), despite regular 
Figure 1. CD36 deficiency inhibits oxLDL uptake by RPE





(B)  and  CD36‐/‐.  (C)  mice.  In  vivo
incorporation  of  fluorescent  DiI‐tagged  oxLDL  (red)  by  retinal
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raised wild type (WT, CD36+/+) congeners. CD36-
dependent cellular uptake of oxLDL was confirmed 
upon systemic administration of fluorescent tagged 
oxLDL; specific uptake of DiI-oxLDL was seen in the 
RPE of CD36+/+ mice (Figure 1D), whereas no 
fluorescence was detected in RPE of CD36-/- mice in 
vivo (Figure 1E). Likewise, exposure of RPE cells from 
CD36+/+ mice to DiI-oxLDL revealed internalization of 
the oxLDL, while no internalization was seen in RPE of  













































CD36 deficiency leads to BM thickening 
 
Lipids are the main component in basal laminar deposits 
[8, 13, 41]. We evaluated if sub-RPE accumulation of 
oxLDL in CD36-/- mice (Figure 1C) is associated with 
BM thickening. Electron microscopy of the sub-retinal 
region revealed age-dependent debris detected in older 
(12 months-old) but not younger (4 months-old) CD36-





























































and  in  double  knockout  ApoE‐/‐CD36‐/‐  mice  under  HFHC
diet  was  evaluated  by  ELISA.  Transmission  electron
microscopy of Bruch’s membrane (BM) thickening (arrows)
in  4  months‐old  ApoE‐/‐  (B)  and  ApoE‐/‐CD36‐/‐  mice  (C)
both  under  HFHC  diet.  (D)  Compiled  BM  thickness  in  4‐
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(ApoE-/-) involved in uptake of LDL, fed a HFHC diet, 
exhibit an atherosclerosis phenotype with high blood 
oxLDL levels [21]; along the lines of the concept 
presented herein, these animals also exhibit laminar 
deposits in BM, as seen in AMD [24]. To further 
address the role of CD36 on oxLDL accumulation and 
BM thickness, oxLDL plasma levels and electron 
microscopy of the sub-retinal region were performed in 
ApoE-/- mice and in ApoE/CD36 double knockout mice 
(ApoE-/-/CD36-/-). oxLDL levels were highest in the 4 
months-old HFHC-fed ApoE/CD36 double knockout 
mice (Figure 3A). In addition, BM thickening was 
further augmented in these relatively young ApoE-/-
/CD36-/- mice (Figure 3B-D). Collectively, data 
indicate that CD36 deficiency is associated with 


































CD36 stimulation prevents thickening of BM and 
preserves (in part) photoreceptor function 
 
 Additional experiments were conducted to determine if 
CD36 stimulation could prevent thickening of BM in 
HFHC-fed ApoE-/- mice. For this purpose animals were 
treated daily either with NaCl or the CD36 agonist 
EP80317 [36] from 8 to 18 weeks of age. HFHC diet 
significantly increased the thickness of BM in saline-
treated ApoE-/- mice (Figure 4B,D), as previously 
reported [24]. Whereas, treatment of ApoE-/- mice with 
EP80317, which reduces plasma cholesterol levels [36], 
prevented the accumulation of sub-RPE deposits and 
thickening of BM (Figure 4C,D).  
 
Along with BM thickening, ApoE-/- mice also present 
photoreceptor dysfunction [24, 25], as evidenced with 
the significantly attenuated rod-cone a-wave amplitude 
of saline-treated ApoE-/-  compared to WT mice 
(Figure 5A, B). Similarly, the significantly attenuated 
rod and rod-cone b-waves (-2.7 log cd.sec.m-2 and 0.6 
log cd.sec.m-2, respectively) are also suggestive of 
inner retinal dysfunction in saline-treated ApoE-/- 
compared to WT mice (Figure 5A, C); treatment of 
ApoE-/- mice with EP80317 significantly attenuated 
the loss of the scotopic rod and rod-cone responses 




The molecular mechanisms that lead to lipid 
accumulation in BM are not well understood. Since 
lipids including oxidized sterols are believed to be an 
important component of sub-retinal debris [42, 43], 
and CD36 is a major scavenger receptor of oxidized 
lipids [29, 30] including in RPE [15], we surmised that 
CD36 modulates sub-retinal deposit formation. We 
found that oxLDL uptake in RPE is CD36-dependent 
in vitro and in vivo. We also showed that in animals 
deficient in CD36 on regular diet, oxLDL accumulated 
sub-retinally and was associated with BM laminar 
deposits analogous to those described in ApoE- and 
LDL receptor-null mice [19, 23-24] fed on high fat 
high cholesterol diet. Moreover, stimulation of CD36 
prevented accumulation of sub-retinal deposits and 
attenuated photoreceptor malfunction. Findings 
suggest that insufficiently prompt clearance of dietary 
lipids is associated with increased circulating levels of 
oxLDL and sub-retinal build-up of these lipids with 
other debris; the scavenger receptor CD36 contributes 
in maintaining integrity of BM.   
 
Bruch’s membrane (BM) is a thin layer of connective 
tissue located between RPE and choroid through 
which essential molecules for chorio-retinal 
homeostasis must be transported [44]. With age BM 
accumulate neutral lipids (triglyceride, esterified 
cholesterol, fatty acid) [7] and lipoprotein-like 
particles [6] comprised in laminar deposits, and lead to 
a decrease in permeability [45, 46].  
Figure 4. CD36 stimulation reduces BM thickness in high




ApoE-/-  mice;  this  effect  was  prevented  by  CD36  stimulation
using EP80317 (EP: 300 µg/kg, sc) (C,D). Scale bars: 1µm. RPE
refers to retinal pigment epithelium, and Ch to choroid. Values
are  mean  ±  SEM;  n=5/group.  **p<0.05  compared  to  values
without asterisks.   
   









































With time these BM deposits and drusen formations in 
the RPE/BM complex ultimately impact RPE and 
photoreceptor integrity [2, 3]; these drusen are also 
composed of cellular debris, proteins such as 
complement [43] and β-amyloid [47-48], and lipids 
including esterified and unesterified cholesterol [8, 49, 
50] and apolipoproteins (ApoE, B, A-I, C-I and C-III) 
[50-53]. Sub-retinal lipids originate in part from RPE 
[43, 51] but also likely from plasma [8], consistent with 
findings in the present study. Accordingly, we found 
that CD36 expressing animals revealed RPE uptake of 
intravenously injected DiI-tagged-oxLDL, while CD36-
null mice exhibited no such uptake from circulation 










































Several receptors are potentially implicated in lipid 
transport in retina [27, 28]. Mice deficient in LDL 
receptor or its ApoE ligand, display an atherosclerosis 
phenotype including high circulating levels of oxLDL 
[21], along with BM thickening, BM lipid deposits and 
RPE basal deposits [19, 23-25]. Although debatable, an 
association between atherosclerosis and human AMD 
has also been described [54-56]. Our observations 
complement these findings, by showing that CD36 
influences the clearance of oxLDL by RPE (Figures 1 
and 3A), affecting (at least partly) sub-retinal structure; 
along these lines, CD36-null mice accumulated over 
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(Figure 4).   
 
In summary, deficiency in uptake of oxidized LDL by 
CD36 expressed on the basolateral side of RPE [32] 
seems to contribute to age-related BM thickening; 
conversely, CD36 activation attenuates BM thickening 
and in parallel preserves visual function. In view of the  
marked paucity in effective therapeutic modalities for 
non-proliferative AMD, pharmacological modulation of 
CD36 activity may be a potential approach for this form 




Animals. The ApoE-/- and ApoE/CD36 double 
deficient (ApoE-/-CD36-/-) mice, obtained as described 
previously [35], were housed at local animal facilities 
under 12 hours light–12 hours dark cycles and fed ad 
libitum with a normal (ND) or a high fat-high 
cholesterol diet (HFHC) (D12108, cholate, AIN-76A 
semipurified diet, Research Diets Inc., NewBrunswick, 
NJ). CD36-/- mice and their controls wild-type 
littermates (CD36+/+) were reproduced separately 
under ND unless otherwise indicated. Eight-week-old 
ApoE-/- mice were treated daily with EP803017 
(300µg/Kg) [36] or vehicule (0.9% NaCl) by 
subcutaneous injections for a period of 10 weeks prior 
to sacrifice. All mice were sacrificed by carbon dioxide 
inhalation or by intraperitoneal injection of 
pentobarbital sodium overdose, prior to ocular 
enucleation. All experimental procedures were done in 
accordance with the Institional Animal Ethics 
Committee and the Canadian Council on Animal Care 
guidelines for use of experimental animals.  
 
Electron microscopy.  Eyes were fixed for 1 h in 2.5% 
glutaraldehyde in cacodylate buffer (0.1 M, pH 7.4). 
After 1 h, the eyes were dissected, fixed for another 3 h, 
postfixed in 1% osmium tetroxide in cacodylate buffer, 
and dehydrated in graduated ethanol solutions. The 
samples were included in epoxy resin and oriented. 
Ultra-thin sections (80 nm) were contrasted by uranyl 
acetate and lead citrate and were observed with an 
electron microscope JEOL 100 CX II (JEOL) with 80 
kV, and measurements of Bruch’s membrane thickness 
were made on three representative animals. 
 
RPE primary culture. Eight at 12-day-old CD36+/+ and 
CD36-/- mice were sacrificed, enucleated and eyes were 
maintained at room temperature overnight in 
Dulbecco’s Modified Eagle’s Medium (DMEM, 
Invitrogen) and then incubated 30 min with 2 mg/ml 
trypsin/collagenase I at 37 °C. After trypsin inhibition 
with DMEM containing 10% fetal calf serum, the RPE 
layer was harvested. The RPE was plated in 8-wells 
labtek (Nunc) at a rate of RPE from one eye per well in 
DMEM containing 10% FCS, 1% penicillin/streptomy- 
cin. Cells were maintained for 7 days before the 
phagocytosis assay. 
 
Phagocytosis assay. Confluent RPE monolayers were 
challenged with DiI-oxLDL (Biomedical Technology 
Inc, MA, USA). When RPE reached 80% of confluence, 
cells were incubated with 30µg/ml DiI-oxLDL for 5 
hours in DMEM containing 5% lipoprotein-deficient 
serum (Biomedical Technology Inc) at 37°C. After 
incubation, no-ingested DiI-oxLDL were removed by 
washing three times with PBS and cells were fixed for 
10 min in paraformaldehyde 4%. The cells were then 
permeabilized for 30 min in 1% triton X-100, blocked 
with 1% bovine serum albumin in PBS for 30 min and 
incubated with 4’, 6-Diamidino-2-phenyl-indole (DAPI) 
(1:4000, Sigma-Aldrich) for 5 min. The slides were 
mounted and observed with a Nikon Eclipse E800. 
 
Intravenous injection of DiI-oxLDL. CD36+/+ and 
CD36-/- mice (2-month-old) were anesthetized and 
intravenous injection of 100 µl of tag DiI coupled or not 
to oxLDL (Biomedical Technology Inc) were given in 
the tail vein. The mice were euthanatized 24 hours after 
injection and eyes were collected and fixed in 4% 
paraformaldehyde in PBS for 2 hours. The tissue was 
then mounted in OCT (Tissue Tek), cut in thin sections 
(10µm). Nuclei were labeled with DAPI (1:4000) and 
sections were mounted with Gelmount (Biomeda). 
Fluorescence was observed with a Nikon Eclipse E800. 
 
Immunofluorescence. Twelve-month-old CD36+/+ and 
CD36-/- mice eyes were fixed in paraformaldehyde 4% 
in PBS for 1 hour at room temperature and rinsed in 
PBS before embedded in OCT. Frozen transverse 
sections 10 µm thick were cut and permeabilized for 10 
min in 1% Triton X-100. Postfixation was performed 
with methanol or ethanol, depending on the antibody 
used. Immunolabeling with primary antibodies (1:100) 
rabbit polyclonal oxLDL (RayBiotech Inc.) was 
performed overnight at room temperature. After 
washing in PBS, secondary antibodies coupled with 
Alexa Fluor 488 (1:100, Molecular Probes) were 
applied for 1 hour at room temperature. Nuclei were 
labeled with DAPI (1:4000) and sections were mounted 
with Gelmount. Fluorescence was observed with an 
Olympus BX51 microscope. All immunostaining were 
repeated at least three times, and staining without 
primary antibody served as negative controls.   
 
OxLDL ELISA. Ten- and 24-month-old C57Bl6/J mice 
(Jackson Laboratory) under ND and 12-week-old 
ApoE-/- mice under ND or HFHC diet and 12-week-old 
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Blood was drawn from the inferior vena cava mice 
using EDTA as an anticoagulant and butylated 
hydroxytoluene (20 µM final concentration) as 
antioxidant. Plasma was collected by centrifugation for 
15 min at 1,000 g. Mouse plasma oxLDL level was 
determined by use of an ELISA kit (Accurate Chemical 
and Scientific Corp, USA).   
 
Electroretinography. Dark adapted scotopic full-field 
electroretinograms (ERG) (intensities:-6.3 log cd.sec.m
-
2  through 0.6 log cd.sec.m
-2) were obtained from 18-
week-old ApoE-/- mice on HFHC diet treated or not 
with EP803017 and WT control-age matched mice as 
we described in detail [37-39].  Amplitudes of ERG a-
wave and b-wave components were measured according 
to a method previously described [37, 38]. Briefly, the 
amplitude of the a-wave was measured from baseline to 
trough, and the b-wave amplitude was measured from 
the trough of the a-wave to the peak of the b-wave.    
 
Statistical analysis. Data between groups (other than for 
ERG) were compared using non-parametric Mann 
Whitney U-test. For ERG data, 2-way repeated 
measures ANOVA (P < 0.05) with Bonferroni post-tests 
were used to compare WT mice to ApoE-/- mice, and to 
determine the effect of EP80317 treatment on the 
different parameters of the ERG as the repeated factor 
and treatment group as the independent factor. All 
analysis and graphic representations were performed 
with Prism software (version 4.0c; GraphPad Software); 
values are represented as mean ± standard error of the 
mean (SEM). P values were calculated for a confidence 
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